Methadone is a potent synthetic analgesic that works as a full µ-opioid receptor (MOR) agonist and N-methyl-d-aspartate (NMDA) receptor antagonist. As a full MOR agonist, methadone mimics the natural effects of the body's opioids, endorphins, and enkephalins through the release of neurotransmitters involved in pain transmission. It also has a number of uniqu...
Methadone is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatment options are inadequate. It's recommended that use is reserved for use in patients for whom alternative treatment options (eg, nonopioid analgesics, opioid combination products) are ineffective, not tolerated, or would be otherwis...
Shriners Hospitals for Children, Sacramento, California, United States
Department of Anaesthesiology and Intensive Care, Randers, Denmark
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
LBR, Puteaux, France
Duke University School of Medicine, Durham, North Carolina, United States
South London and Maudsley NHS Foundation Trust, London, United Kingdom
NHS Tayside, Dundee, United Kingdom
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom
Hospital das Clínicas da FMUSP, Sao Paulo, SP, Brazil
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.